09.07.2021 14:35:38

Eurofins, Rite Aid Launch FDA-authorised, At-home COVID-19 PCR Test Kit - Quick Facts

(RTTNews) - Eurofins Scientific (ERFSF.PK), through its empowerDX subsidiary, and Rite Aid announced Friday the launch of an over-the-counter, FDA-authorised, at-home COVID-19 PCR Test Kit.

The co-branded kits, available at all Rite Aid stores across 17 states in the U.S., will offer customers a convenient way to test for the virus from their home and will detect the virus in symptomatic and asymptomatic patients.

The at-home COVID-19 nasal PCR kit is among the first over-the-counter at-home test kits for SARS-CoV-2 to receive US Food and Drug Administration Emergency Use Authorization (EUA).

The test was developed by Eurofins Viracor, a leading infectious disease testing laboratory, and is based on its FDA EUA authorised SARS-CoV-2 RT-PCR assay.

As of December 2020, this later assay offers one of the best sensitivity rates of 117 laboratories that have submitted results to the FDA's SARS-CoV-2.

Nachrichten zu Rite Aid Corp Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Rite Aid Corp Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Rite Aid Corp Registered Shs 0,70 -74,26% Rite Aid Corp Registered Shs